Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease
Yıl: 2022 Cilt: 3 Sayı: 2 Sayfa Aralığı: 39 - 40 Metin Dili: İngilizce DOI: 10.14744/hf.2022.2022.0002 İndeks Tarihi: 18-05-2023
Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Erişime Açık
- 1. Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology. 2020 Nov;72(5):1605-1616.
- 2. Paik JM, Kabbara K, Eberly KE, Younossi Y, Henry L, Younossi ZM. Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. 2021 Nov 6. doi: 10.1002/hep.32228. Epub ahead of print. PMID: 34741554.
- 3. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dys- function-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020 Jul;73(1):202-209.
- 4. Demirtas CO, Yilmaz Y. Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice? Hepa- tology Forum 2020;1(3):79-81.
- 5. Nastasa R, Stanciu C, Zenovia S, Singeap AM, Cojocariu C, Sfarti C, et al. The prevalence of liver steatosis and fibrosis assessed by vibra- tion-controlled transient elastography and controlled attenuation parame- ter in apparently healthy romanian medical students. Diagnostics (Basel) 2021;11(12):2341.
- 6. Kaya E, Demir D, Alahdab YO, Yilmaz Y. Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter. Eur J Gastroenterol Hepatol 2016;28(11):1264-1267.
- 7. Arshad T, Paik JM, Biswas R, Alqahtani SA, Henry L, Younossi ZM. Non- alcoholic fatty liver disease prevalence trends among adolescents and young adults in the United States, 2007-2016. Hepatol Commun 2021;5(10):1676- 1688.
- 8. Aziz B, Nazar T, Irfan M. The frequency of non-alcoholic fatty liv- er disease in non-obese young medical professionals. J Pak Med Assoc 2021;71(7):1878- 1881.
- 9. Okur G, Karacaer Z. The prevalence of non-alcoholic fatty liver disease in healthy young persons. North Clin Istanb. 2016;3(2):111-117.
- 10. Tomah S, Hamdy O, Abuelmagd MM, Hassan AH, Alkhouri N, Al-Badri MR, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt. BMJ Open Gastroen- terol 2021;8(1):e000780.
- 11. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64(1):73-84.
- 12. Attar BM, Van Thiel DH. Current concepts and management approaches in nonalcoholic fatty liver disease. ScientificWorldJournal 2013;2013:481893.
- 13. Zhang X, Wu M, Liu Z, Yuan H, Wu X, Shi T, et al. Increasing preva- lence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open 2021;11(5):e042843.
- 14. Simon TG, Roelstraete B, Hartjes K, Shah U, Khalili H, Arnell H, et al. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. J Hepatol. 2021 Nov;75(5):1034-1041.
- 15. Golabi P, Paik J, Reddy R, Bugianesi E, Trimble G, Younossi ZM. Preva- lence and long-term outcomes of non-alcoholic fatty liver disease among el- derly individuals from the United States. BMC Gastroenterol 2019;19(1):56.
- 16. Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, et al. An obser- vational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol 2021:S1542- 3565(21)01276-3. doi: 10.1016/j.cgh.2021.11.038. [Epub ahead of print]
- 17. Yilmaz Y, Yilmaz N, Ates F, Karakaya F, Gokcan H, Kaya E, et al. The prev- alence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study. Hepatology Forum 2021;2(2):37-42.
- 18. Li H, Guo M, An Z, Meng J, Jiang J, Song J, et al. Prevalence and risk factors of metabolic associated fatty liver disease in xinxiang, China. Int J Environ Res Public Health. 2020;17(6):1818.
| APA | Kaya E, Yilmaz Y (2022). Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. , 39 - 40. 10.14744/hf.2022.2022.0002 |
| Chicago | Kaya Eda,Yilmaz Yusuf Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. (2022): 39 - 40. 10.14744/hf.2022.2022.0002 |
| MLA | Kaya Eda,Yilmaz Yusuf Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. , 2022, ss.39 - 40. 10.14744/hf.2022.2022.0002 |
| AMA | Kaya E,Yilmaz Y Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. . 2022; 39 - 40. 10.14744/hf.2022.2022.0002 |
| Vancouver | Kaya E,Yilmaz Y Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. . 2022; 39 - 40. 10.14744/hf.2022.2022.0002 |
| IEEE | Kaya E,Yilmaz Y "Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease." , ss.39 - 40, 2022. 10.14744/hf.2022.2022.0002 |
| ISNAD | Kaya, Eda - Yilmaz, Yusuf. "Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease". (2022), 39-40. https://doi.org/10.14744/hf.2022.2022.0002 |
| APA | Kaya E, Yilmaz Y (2022). Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. Hepatology forum, 3(2), 39 - 40. 10.14744/hf.2022.2022.0002 |
| Chicago | Kaya Eda,Yilmaz Yusuf Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. Hepatology forum 3, no.2 (2022): 39 - 40. 10.14744/hf.2022.2022.0002 |
| MLA | Kaya Eda,Yilmaz Yusuf Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. Hepatology forum, vol.3, no.2, 2022, ss.39 - 40. 10.14744/hf.2022.2022.0002 |
| AMA | Kaya E,Yilmaz Y Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. Hepatology forum. 2022; 3(2): 39 - 40. 10.14744/hf.2022.2022.0002 |
| Vancouver | Kaya E,Yilmaz Y Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease. Hepatology forum. 2022; 3(2): 39 - 40. 10.14744/hf.2022.2022.0002 |
| IEEE | Kaya E,Yilmaz Y "Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease." Hepatology forum, 3, ss.39 - 40, 2022. 10.14744/hf.2022.2022.0002 |
| ISNAD | Kaya, Eda - Yilmaz, Yusuf. "Insidious danger for young adults: Metabolic (dysfunction)- associated fatty liver disease". Hepatology forum 3/2 (2022), 39-40. https://doi.org/10.14744/hf.2022.2022.0002 |
